Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.7 (
BAL
)
1,977
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Antigen-presenting cells (APCs) are strategically placed in all anatomic sites with high antigen exposure such as the respiratory system. The aim of this study was to evaluate phenotypic and functional properties of APCs from the lung (L-Cs), mediastinal lymph node (LN-Cs) and bronchoalveolar lavage cells (BAL-Cs). The APCs were first analyzed based on forward scatter and side scatter profiles and the selection of MHC-II(high)CD172a(+) cells (referred to as APCs); then the expression of CD1a, CD163,
CD206
, CD16 and CD11R3 was evaluated in the APCs. The results showed that CD1a, CD163 and
CD206
were differentially expressed among L-Cs, LN-Cs and
BAL
-Cs, suggesting the phenotype MHC-II(high)CD172a(+)CD1a(low/-)CD163(low)
CD206
(-) for L-Cs and MHC-II(high)CD172a(+)CD1a(+)CD163(low/-)
CD206
(+) for LN-Cs.
BAL
-Cs were MHC-II(high)CD172a(+)CD1a(-)CD163(high)
CD206
(+/-). The functional characteristics of L-Cs and LN-Cs were different from those of
BAL
-Cs, confirming that L-Cs and LN-Cs resemble specialized APCs. In conclusion, we present the characterization of APCs from L-Cs, LN-Cs and
BAL
-Cs of the porcine respiratory system.
...
PMID:Characterization of antigen-presenting cells from the porcine respiratory system. 2595 37